Risk of multiple primary malignancies following treatment of Hodgkin lymphoma.
van Eggermond AM, Schaapveld M, Lugtenburg PJ, Krol AD, de Boer JP, Zijlstra JM, Raemaekers JM, Kremer LC, Roesink JM, Louwman MW, Aleman BM, van Leeuwen FE.
van Eggermond AM, et al. Among authors: krol ad.
Blood. 2014 Jul 17;124(3):319-27; quiz 466. doi: 10.1182/blood-2013-10-532184. Epub 2014 Apr 16.
Blood. 2014.
PMID: 24740811
Free article.